Edition:
United States

Nanobiotix SA (NANOB.PA)

NANOB.PA on Paris Stock Exchange

17.49EUR
18 Sep 2018
Change (% chg)

-- (--)
Prev Close
€17.49
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
200,979
52-wk High
€18.87
52-wk Low
€8.30

Chart for

About

Nanobiotix SA is a France-based oncology focused nanomedicine company. It is engaged in developing nanoparticle technology. It develops new tools for cancer which utilize a physical mode of action at the cellular level of the cancer cell. This disruptive approach may reshape future treatment opportunities. The Company's NanoXray... (more)

Overall

Beta: 1.95
Market Cap(Mil.): €341.03
Shares Outstanding(Mil.): 19.63
Dividend: --
Yield (%): --

Financials

  NANOB.PA Industry Sector
P/E (TTM): -- 103.50 32.14
EPS (TTM): -1.37 -- --
ROI: -74.25 1.52 12.66
ROE: -84.02 0.25 14.84

BRIEF-Nanobiotix Did Not Generate Any Revenue In Q1

* ANNOUNCED ON TUESDAY IT DID NOT GENERATE ANY REVENUE FOR Q1 2018, AS IT HAD EXPECTED

May 16 2018

BRIEF-Nanobiotix Partners With Weill Cornell Medicine

* PARTNERSHIP ON PRE-CLINICAL STUDIES TO EVALUATE NBTXR3 IMPACT ON CGAS-STING PATHWAY IN MAMMARY CANCERS

May 03 2018

BRIEF-Nanobiotix FY Net Loss Widens to ‍​26.1 Million Euros

* TOTAL REVENUE IN 2017 AMOUNTS TO EUR 3.7M VERSUS. EUR 5.4M IN 2016

Mar 30 2018

Earnings vs. Estimates